Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women

Digestion

Volumn 91, Issue 2, 2015, Pages 150-157

  Sinn, Dong Hyun ^a   Gwak, Geum Youn ^a   Rhee, Sang Youl ^b   Cho, Juhee ^c,d   Son, Hee Jung ^a   Paik, Yong Han ^a   Choi, Moon Seok ^a   Lee, Joon Hyeok ^a   Koh, Kwang Cheol ^a   Yoo, Byung Chul ^a   Paik, Seung Woon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone mineral density; Menopause; Non alcoholic fatty liver disease; Osteocalcin; Women

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PHOSPHATE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LOW DENSITY LIPOPROTEIN; PHOSPHATASE;

ADULT; ARTICLE; BONE DENSITY; DIET RESTRICTION; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGED; ANALYSIS; BLOOD; QUESTIONNAIRE; RISK;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BONE DENSITY; CALCIUM; FASTING; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIPOPROTEINS, LDL; MENOPAUSE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; OSTEOCALCIN; PHOSPHORIC MONOESTER HYDROLASES; PREMENOPAUSE; QUESTIONNAIRES; TRIGLYCERIDES;

EID: 84923082824     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000369789     Document Type: Article

References (26)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ: The diagnosis and management of nonalcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
2. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J: NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379.
3. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43:S99-S112.
4. Kim YS, Paik IY, Rhie YJ, Suh SH: Integrative physiology: defined novel metabolic roles of osteocalcin. J Korean Med Sci 2010; 25: 985-991.
5. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469.
6. Atalay S, Elci A, Kayadibi H, Onder CB, Aka N: Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 2012; 32: 23-30.
7. Neve A, Corrado A, Cantatore FP: Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 2013; 228: 1149-1153.
8. Ferron M, Hinoi E, Karsenty G, Ducy P: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270.
9. Hwang YC, Jeong IK, Ahn KJ, Chung HY: Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int 2012; 23: 1337-1342.
10. Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T: Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 2011; 48: 720-725.
11. Yilmaz Y, Kurt R, Eren F, Imeryuz N: Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scand J Clin Lab Invest 2011; 71: 631-636.
12. Moon SS, Lee YS, Kim SW: Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 2012; 42: 423-429.
13. Kim SM, Kim KM, Kim BT, Joo NS, Kim KN, Lee DJ: Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women. J Korean Med Sci 2010; 25: 1171-1175.
14. Saverymuttu SH, Joseph AE, Maxwell JD: Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986; 292: 13-15.
15. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM: Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.
16. Shin SY, Lee JR, Noh GW, Kim HJ, Kang WJ, Kim SH, Chung JK: Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulinlike growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status. J Korean Med Sci 2008; 23: 104-110.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
18. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, Cho GJ, Han JH, Kim SR, Park CY, Oh SJ, Lee CB, Kim KS, Oh SW, Kim YS, Choi WH, Yoo HJ: Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes 2006; 15: 1-9.
19. Suk JH, Cho EH, Lee SY, Kim JW: [Laboratory evaluation of bone metabolism index using elecsys 2010]. Korean J Lab Med 2006; 26: 146-152.
20. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50: 1105-1112.
21. Fernandez-Real JM, Ricart W: Osteocalcin: a new link between bone and energy metabolism. Some evolutionary clues. Curr Opin Clin Nutr Metab Care 2011; 14: 360-366.
22. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM: Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 2011; 96:E1982-E1989.
23. Cohen JC, Horton JD, Hobbs HH: Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
24. Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, Saksouk FA, Wheeler DE, Ehrinpreis MN: Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007; 41: 624-629.
25. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ: Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-1067.
26. Ahn JS, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC: Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. Transplantation 2013; 95: 1404-1409.